HCR Wealth Advisors Trims Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

HCR Wealth Advisors cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,706 shares of the financial services provider’s stock after selling 2,747 shares during the quarter. HCR Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $1,559,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Future Financial Wealth Managment LLC acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $27,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF in the second quarter valued at $31,000. Pacifica Partners Inc. raised its position in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares during the period. Mather Group LLC. acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at about $57,000. Finally, Chris Bulman Inc purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $64,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.7 %

IBB traded up $2.44 during trading on Friday, hitting $145.59. The company’s stock had a trading volume of 2,178,921 shares, compared to its average volume of 1,483,730. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The business’s fifty day simple moving average is $145.12 and its 200 day simple moving average is $139.34.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.